Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial | The Journal of Headache and Pain | Full Text
▷ Autofficina Midas, Pavia
▷ Autofficina Midas, Pavia
The early phase of the COVID-19 epidemic in Lombardy, Italy. – MIDAS
Midas DN9610 - Prase Media Technologies
89 recensioni di Autofficina Midas a Pavia
Alberto De Nova - Founder, Managing Director - MIDAS | LinkedIn
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial | The Journal of Headache and Pain | Full Text